Xcout IntelKorro Bio, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Korro Bio, Inc. among biotech companies — ranked by similarity to what Korro Bio, Inc. actually does, not by market-cap band.
Subscribe to see Korro Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Korro Bio, Inc. at a glance
Korro Bio, Inc. is a biotech company headquartered in Cambridge, United States. It is publicly listed (KRRO) with a market capitalisation of $101.1M. Xcout tracks 17 named people at Korro Bio, Inc., including Ram Aiyar (Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director). Xcout recorded 6 job postings from Korro Bio, Inc. in the last 90 days.
Korro Bio, Inc. leadership
- Ram AiyarChief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director
- Todd ChappellChief Operating Officer
- Loic VincentChief Scientific Officer
- Stephanie EngelsChief People Officer
- Jean-Francois FormelaCo-Founder & Director
- Andrew FraleyCo-Founder & Advisor
11 more named people on record for Korro Bio, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Korro Bio, Inc.
Xcout recorded 6 job postings from Korro Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Korro Bio, Inc.'s hiring signals →
Top 12 Korro Bio, Inc. competitors
Ranked by semantic similarity — how close each company is to Korro Bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Similar biotech company
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Biotechnology
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Biotechnology
KOMO Biosciences is a biotechnology research company headquartered in Cambridge, Massachusetts. The company specializes in next-generation precision genome engineering driven by highly efficient, evolved integrases.
Similar biotech company
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Biotechnology
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Biotechnology
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Biotechnology
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Biotechnology
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Biotechnology
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
Biotechnology
Hunterian Medicine LLC is a gene-editing company that develops CRISPR-based therapeutics to cure genetic diseases. The company utilizes a patented platform technology with a bidirectional promoter to enable efficient, on-target delivery of CRISPR via a single adeno-associated virus (AAV).
Biotechnology
EditForce, Inc. is a biotechnology company headquartered in Fukuoka, Japan, known for realizing the world's first RNA-editing technology of "U-to-C". The company focuses on advanced RNA research and therapeutic applications.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Korro Bio, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Korro Bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →